Among 708 liver transplant patients, those with high disease severity (MELD scores ≥20) and mild-to-severe tricuspid regurgitation faced 3.46 times higher risk of death within one year compared to those without this heart valve condition. The study tracked 1,031 patients from 2010-2023, finding that while tricuspid regurgitation didn't predict mortality in the overall population, it became a critical risk factor specifically in sicker patients requiring transplants. This heart-liver connection reflects how advanced liver disease can strain the cardiovascular system through complex hemodynamic changes. The finding could reshape pre-transplant risk assessment protocols, potentially identifying patients who need intensive cardiac monitoring or intervention before surgery. However, this retrospective analysis has inherent limitations in establishing causation, and the relatively small subgroup of high-MELD patients with tricuspid regurgitation warrants cautious interpretation. As this research awaits peer review, the results may be refined through the editorial process. The discovery represents an important but incremental advance in transplant medicine, offering clinicians a more nuanced tool for patient selection and perioperative planning in an already high-risk population.